Ankylosing Spondylitis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

US Market Report for Ankylosing Spondylitis Immunology Drugs 2018 - MedCore - PR Newswire (press release)



US Market Report for Ankylosing Spondylitis Immunology Drugs 2018 - MedCore 
PR Newswire (press release)
Ankylosing spondylitis (AS) is a form of arthritis, primarily affecting the spine. AS causes an inflammation in vertebrae and can lead to severe chronic pain and significantly decreases the quality of life. In severe cases the disease can lead to ...

and more » 


TNF Inhibitors Decrease Extraarticular Manifestations in Ankylosing Spondylitis - Rheumatology Advisor



Rheumatology Advisor
 
TNF Inhibitors Decrease Extraarticular Manifestations in Ankylosing Spondylitis 
Rheumatology Advisor
SAN DIEGO ? Tumor necrosis factor (TNF) inhibitors were shown to reduce the incidence and prevalence of comorbidities and extraarticular manifestations among patients with ankylosing spondylitis, according to research to be presented at the American ...

 


Psoriatic Arthritis, Ankylosing Spondylitis Treatment Gets Approval - Pharmacy Times



Psoriatic Arthritis, Ankylosing Spondylitis Treatment Gets Approval 
Pharmacy Times
The FDA has announced the approval of 2 Supplemental Biologics License Applications (sBLAs) for golimumab (Simponi Aria) for 2 new indications: the treatment of adults with psoriatic arthritis (PsA) and adults with active ankylosing spondylitis (AS).

 


Novartis to Present Promising 4-year Data of Cosentyx at International Conference - Ankylosing Spondylitis News



Ankylosing Spondylitis News
 
Novartis to Present Promising 4-year Data of Cosentyx at International Conference 
Ankylosing Spondylitis News
Novartis will present new four-year data from the MEASURE 1 study showing how Cosentyx (secukinumab) benefits patients with ankylosing spondylitis at the 2017 ACR/ARHP Annual Meeting in San Diego, Nov. 3-8. The data shows that Cosentyx is capable ...

 


UPDATE 1-Novartis pitches new Cosentyx data as immunology crowd grows - Reuters



UPDATE 1-Novartis pitches new Cosentyx data as immunology crowd grows 
Reuters
ZURICH, Nov 6 (Reuters) - Novartis on Monday stepped up its defence of Cosentyx amid rising competition from other immunology medicines, with data indicating its drug halted damage to ankylosing spondylitis (AS) patients' spines after four years of ...

and more » 


Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis - Monthly Prescribing Reference



Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis 
Monthly Prescribing Reference
Janssen Biotech announced that the Food and Drug Administration (FDA) has approved Simponi Aria (golimumab) for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS). Simponi Aria, a fully-human anti-tumor ...

 


Novartis' Cosentyx Shows Very Little Radiographic Progression in Ankylosing Spondylitis Patients - Ankylosing Spondylitis News



Novartis' Cosentyx Shows Very Little Radiographic Progression in Ankylosing Spondylitis Patients 
Ankylosing Spondylitis News
Novartis recently reported that long-term radiographic data from a clinical trial showed that treatment of ankylosing spondylitis (AS) with Cosentyx (secukinumab) resulted in no disease progression in a vast majority of the patients analyzed. The multi ...

 


European Commission Approves Cyltezo, Humira's Biosimilar, for Chronic Inflammatory Diseases - Ankylosing Spondylitis News



Ankylosing Spondylitis News
 
European Commission Approves Cyltezo, Humira's Biosimilar, for Chronic Inflammatory Diseases 
Ankylosing Spondylitis News
Boehringer Ingelheim announced that the European Commission has granted marketing authorization for Cyltezo, a biosimilar to Humira (adalimumab), for the treatment of ankylosing spondylitis (AS) and other chronic inflammatory diseases in adults and ...

and more » 


Obesity Can Make Axial Spondyloarthropathy Worse, Irish Study Finds - Ankylosing Spondylitis News



Obesity Can Make Axial Spondyloarthropathy Worse, Irish Study Finds 
Ankylosing Spondylitis News
They collected information from the Ankylosing Spondylitis Registry of Ireland on 683 patients with ankylosing spondylitis, a type of axSpa. Patients had had the disease an average of 19 years. Their average age was 46. Seventy percent were men. A look ...

 


Ankylosing Spondylitis (Bekhterev's Disease) Market Research Report 2017 - Research of Market



Ankylosing Spondylitis (Bekhterev's Disease) Market Research Report 2017 
Research of Market
Ankylosing Spondylitis-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Ankylosing Spondylitis. The report provides a complete understanding of the pipeline ...

and more »